Fresenius Medical (Germany) Performance
| FMEA Stock | EUR 21.60 0.40 1.89% |
On a scale of 0 to 100, Fresenius Medical holds a performance score of 11. The firm shows a Beta (market volatility) of -0.33, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Fresenius Medical are expected to decrease at a much lower rate. During the bear market, Fresenius Medical is likely to outperform the market. Please check Fresenius Medical's semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and standard deviation , to make a quick decision on whether Fresenius Medical's price patterns will revert.
Risk-Adjusted Performance
11 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Fresenius Medical Care are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain technical and fundamental indicators, Fresenius Medical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 1.5 B |
Fresenius |
Fresenius Medical Relative Risk vs. Return Landscape
If you would invest 1,820 in Fresenius Medical Care on October 12, 2024 and sell it today you would earn a total of 340.00 from holding Fresenius Medical Care or generate 18.68% return on investment over 90 days. Fresenius Medical Care is generating 0.314% of daily returns assuming 2.175% volatility of returns over the 90 days investment horizon. Simply put, 19% of all stocks have less volatile historical return distribution than Fresenius Medical, and 94% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Fresenius Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fresenius Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Fresenius Medical Care, and traders can use it to determine the average amount a Fresenius Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1444
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | FMEA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.17 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.31 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average Fresenius Medical is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fresenius Medical by adding it to a well-diversified portfolio.
Fresenius Medical Fundamentals Growth
Fresenius Stock prices reflect investors' perceptions of the future prospects and financial health of Fresenius Medical, and Fresenius Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fresenius Stock performance.
| Return On Equity | 0.0608 | |||
| Return On Asset | 0.0277 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 21.71 B | |||
| Shares Outstanding | 586.83 M | |||
| Price To Earning | 14.69 X | |||
| Price To Book | 0.58 X | |||
| Price To Sales | 0.46 X | |||
| Revenue | 19.4 B | |||
| EBITDA | 3.42 B | |||
| Cash And Equivalents | 922.1 M | |||
| Cash Per Share | 1.52 X | |||
| Total Debt | 7.17 B | |||
| Debt To Equity | 105.10 % | |||
| Book Value Per Share | 23.84 X | |||
| Cash Flow From Operations | 2.17 B | |||
| Earnings Per Share | 1.20 X | |||
| Total Asset | 35.75 B | |||
About Fresenius Medical Performance
By analyzing Fresenius Medical's fundamental ratios, stakeholders can gain valuable insights into Fresenius Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Fresenius Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Fresenius Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. FRESENIUS is traded on Frankfurt Stock Exchange in Germany.Things to note about Fresenius Medical Care performance evaluation
Checking the ongoing alerts about Fresenius Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Fresenius Medical Care help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Fresenius Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Fresenius Medical Care has accumulated 7.17 B in total debt with debt to equity ratio (D/E) of 105.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Fresenius Medical Care has a current ratio of 0.97, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Fresenius Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Fresenius Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Fresenius Medical Care sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Fresenius to invest in growth at high rates of return. When we think about Fresenius Medical's use of debt, we should always consider it together with cash and equity. |
- Analyzing Fresenius Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fresenius Medical's stock is overvalued or undervalued compared to its peers.
- Examining Fresenius Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Fresenius Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fresenius Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Fresenius Medical's stock. These opinions can provide insight into Fresenius Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Fresenius Stock analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |